Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised

Network Portfolio Roadmap

European Medicines Agency (EMA) and European Association of Urology (EAU) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 October 2025, 16:30 (CEST) to 2 October 2025, 17:30 (CEST)

PSUSA/00002398/202411

Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 9, Status: Authorised

First European Medicines Agency (EMA) and European Association for the Study of Diabetes (EASD) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2025, 10:30 (CEST) to 26 September 2025, 12:00 (CEST)

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 2025

Summary of opinion: Bravecto TriUNO, 10/09/2025 Positive

Veterinary medicines European public assessment report (EPAR): Portela, relfovetmab, Status: Opinion